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Abstract
Background: Preeclampsia is one of the leading causes of maternal and perinatal morbidity and mortality world-wide.
The risk for developing preeclampsia varies depending on the underlying mechanism. Because the disorder is
heterogeneous, the pathogenesis can differ in women with various risk factors. Understanding these mechanisms of
disease responsible for preeclampsia as well as risk assessment is still a major challenge. The aim of this study was to
determine the risk factors associated with preeclampsia, in healthy women in maternity hospitals of Karachi and
Rawalpindi.
Methods: We conducted a hospital based matched case-control study to assess the factors associated with
preeclampsia in Karachi and Rawalpindi, from January 2006 to December 2007. 131 hospital-reported cases of PE and
262 controls without history of preeclampsia were enrolled within 3 days of delivery. Cases and controls were matched
on the hospital, day of delivery and parity. Potential risk factors for preeclampsia were ascertained during in-person
postpartum interviews using a structured questionnaire and by medical record abstraction. Conditional logistic
regression was used to estimate matched odds ratios (ORs) and 95% confidence intervals (95% CIs).
Results: In multivariate analysis, women having a family history of hypertension (adjusted OR 2.06, 95% CI; 1.27-3.35),
gestational diabetes (adjusted OR 6.57, 95% CI; 1.94 -22.25), pre-gestational diabetes (adjusted OR 7.36, 95% CI; 1.3733.66) and mental stress during pregnancy (adjusted OR 1.32; 95% CI; 1.19-1.46, for each 5 unit increase in Perceived
stress scale score) were at increased risk of preeclampsia. However, high body mass index, maternal age, urinary tract
infection, use of condoms prior to index pregnancy and sociodemographic factors were not associated with higher risk
of having preeclampsia.
Conclusions: Development of preeclampsia was associated with gestational diabetes, pregestational diabetes, family
history of hypertension and mental stress during pregnancy. These factors can be used as a screening tool for
preeclampsia prediction. Identification of the above mentioned predictors would enhance the ability to diagnose and
monitor women likely to develop preeclampsia before the onset of disease for timely interventions and better
maternal and fetal outcomes.
Background
Preeclampsia (PE) is a pregnancy-specific condition and
is associated with high maternal mortality and morbidity
as well as risk of perinatal death, preterm birth, and intrauterine growth restriction[1]. It occurs in 4 to 7 per cent
of pregnant women worldwide [2]. The etiology of preeclampsia remains unclear despite extensive research. Risk
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factors for preeclampsia include nulliparity, a family or
own history of PE, pre-existing diabetes or increased
body mass index, multiple pregnancy, maternal age, renal
disease, hypertension or raised blood pressure at booking
and chronic autoimmune disease [3]. The rate of preeclampsia has increased worldwide especially in developed
countries by 40% between 1990 and 1999 due to an
increase in number of older mothers and multiple births,
conditions known to increase its risk[4].
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Maternal Mortality is extremely high in Pakistan where
1 in 89 women dies of maternal causes with preeclampsia
and eclampsia as one of the major causes [5]. As preeclampsia remains a serious and poorly understood complication of pregnancy, we need to identify epidemiological
and clinical risk factors to predict it before it threatens
the survival of both mother and fetus. The study of risk
factors and the underlying evidence base can be used to
assess risk of preeclampsia at antenatal booking [6].
There is paucity in studies on preeclampsia and its associated factors in Pakistan; an economically developing
country in Asia.
This study was conducted to determine factors associated with PE, in healthy women with single pregnancy in
maternity hospitals of Karachi and Rawalpindi. Moreover,
this study investigated the association between family
history of hypertension and preeclampsia.

Methods
This matched case control study was conducted between
January 2006-December 2007 in six selected maternity
hospitals in Karachi and two maternity hospitals in
Rawalpindi: Aga Khan University Hospital, Sohbraj
Maternity Hospital, Aga Khan Maternity hospital for
women, Karimabad, Aga Khan Maternity hospital for
Women & Children, Garden, Lady Dufferin Hospital and
Jinnah Postgraduate Medical Centre Hospital in Karachi,
and Combined Military Hospital and Military Hospital in
Rawalpindi.
All pregnant women of any age delivering in any of the
above-mentioned hospitals were potential study subjects.
We excluded women with past histories of chronic hypertension, and multiple gestations in current pregnancies.
A case was defined as a woman who had given birth
during the preceding three days and who, in the antenatal period or before going into labor, was diagnosed by
an obstetrician as being preeclamptic. Preeclampsia was
defined as pregnancy-induced hypertension associated
with proteinuria. Pregnancy-induced hypertension was
defined as new hypertension with blood pressure of 140
mm Hg systolic or diastolic B.P of 90 mm Hg diastolic or
greater arising after 20 weeks of gestation in a woman
who was normotensive before 20 weeks gestation. Proteinuria was defined as excretion of 300 mg or more of protein in 24 hour urine sample or 1+ or more on dipstick
(ICD-9 codes 642E-Fand ICD -10 code O15).
A control was defined as a woman who gave birth during the preceding 3 days and who did not have a diagnosis
of preeclampsia. For each case we interviewed two controls who delivered on the same day in the same hospital
matched on parity. In total 131 cases and 232 controls
were interviewed. The hospital's register was surveyed
each day by the study team members to identify all preeclamptic cases, and potential controls. Prior to the inter-
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view, informed consent was obtained from all study
participants. Women with preexisting chronic hypertension, defined as BP greater than 140/90 mmHg before
pregnancy or before 20 weeks' gestation, were excluded.
The data collection was conducted on the post delivery
ward by the specialized doctors using a structured questionnaire. Women with singleton gestations delivered
after 20 weeks were eligible for inclusion. They were
interviewed at enrollment and within 3 days of delivery.
The questionnaire included information regarding sociodemographic characteristics, antenatal history and family
history of hypertension and diabetes apart from other
covariates.
Potential risk factors were selected on the basis of literature review and biological plausibility for an association
with both the exposure and outcome. The covariates
included in the analysis were maternal age, maternal
smoking, gestational diabetes, diabetes mellitus, stress
measured by Perceived Stress Score PSS, sociodemographic status, age at menarche, body mass index, urine
tract infections, past history of PE, family history of
hypertension, diabetes mellitus, use of condoms, age of
husband, sex of the baby, blood group and RH factor. Diabetes mellitus and gestational diabetes were self reported
by the participants and verified by the medical records.
Perceived Stress Scale (PSS) used was a 10-item measure
of stressful situations during the past month [7]. Items are
scored on a five-point scale from 0 to 4; the total score
provides a global measurement of the extent to which an
individual feels overwhelmed. Total scores range from 0
to 40; higher scores indicate greater perceived stress. As
we don't have the data on incidence or prevalence of PE in
Pakistan therefore the prevalence of various risk factors
for pre-eclampsia was ascertained through literature
search. In the sample size calculation, we assumed the
prevalence of the various risk factors amongst the control
group to be in the range of 11-72%. The prevalence of
Diabetes in Pakistan is 11%. With low prevalence of disease as well as time and financial constraints, we took the
option of taking a 1:2 ratio between cases and controls to
increase the power of the study. Thence in order to be
able to detect an odds ratio of at least 2 with a power of
80%, at a significance level of 5%, we calculated a sample
size of 187 cases and 374 controls. {NCSS statistical software & power analysis sample size PASS}.
All data analyses were performed using SAS, version
9.1, for windows (SAS Institute Inc. North Carolina) and
SPSS 16. To identify the factors associated with PE, univariate matched analysis was done by comparing the
cases and controls (1 case: 2 controls) for each variable of
interest and crude matched odds ratio and their 95% confidence intervals along with p values were calculated. In
multivariable analysis, matched analysis in logistic
regression was performed to identify associated factors of
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PE while adjusting for other variables. Finally any variable
with p-value > 0.05, not a confounder or interacting with
other variables were removed from the model to obtain a
parsimonious and biologically meaningful model that
best explains the phenomena of PE.
The study was approved by the Ethical Review Board of
Aga Khan University Hospital.

Results
The sociodemographic, obstetric and antenatal characteristics of all participants are presented in table 1. The
actual sample size achieved was a total of 131 cases
matched on parity, day of delivery and hospital with 262
controls participated in the study of preeclampsia risk
factors. There were 194 nulliparous women and 199
parous women with single pregnancy. No significant differences were observed between cases and controls with
regard to maternal age, age at menarche, maternal education, socioeconomic status measured by ownership of
house, number of rooms in household, number of household members, husband's occupation.
Gestational diabetes was higher among cases (12.4%) as
compared to controls (1.9%). Urine tract infections during pregnancy were higher among cases compared to
controls (31% among cases and 18.5% among controls).
Pregestational diabetes was higher among cases (5.6%)
compared to controls (0.8%). Family history of diabetes
among first relatives was 43.8% among cases and 29.6%
among controls. Family history of hypertension among
cases was 58.9% as compared to 38.5% among controls.
Mean Perceived stress score was 22 among cases as compared to 20 among controls. The mean prepregnancy
weight for cases was 57.3 kg and for controls it was 55
kgs. There were no differences among cases and controls
with regard to age of husbands, condom use around conception, sex of baby, maternal height, BMI, Blood group
and Rh factor.
Referring to table 2, the significant variables in the final
model were history of gestational diabetes, pregestational
diabetes mellitus, family history of hypertension and perceived stress score. After adjusting for the effect of other
variables in the model it was found that gestational diabetes was independently associated with preeclampsia.
Women with gestational diabetes were at greater odds of
having preeclampsia as compared to those who had no
gestational diabetes (OR = 6.57, CI; 1.94-22.25).
Similarly history of pre-gestational diabetes was independently associated with preeclampsia. Women with a
history of pre-gestational diabetes were at greater odds of
having preeclampsia as compared to women without pregestational diabetes (OR = 7.36, CI; 1.37-33.66).
Our study showed that the family history of hypertension was an important risk factor for preeclampsia. Cases
were 2.3 times more likely to have a positive family his-
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tory of hypertension as compared to controls, while keeping no family history of hypertension as the reference
category (OR = 2.06, CI; 1.27-3.35).
Mental stress during pregnancy, measured by Perceived
Stress Scale, was also associated with increased risk of PE
(OR = 1.32; CI; 1.19-1.46). For each 5 unit increase in the
stress score the risk of preeclampsia increased by 1.32.
There was no collinearity between variables included in
the final model.

Discussion
This is the first report of a hospital based case control
study to determine preeclampsia risk factors among
women in Karachi and Rawalpindi. Participants provided
information on all the potential risk factors during postpartum interviews.
Our results showed that gestational diabetes mellitus
(GDM) was associated with the subsequent development
of preeclampsia. The result of our study showing a relationship between preeclampsia and diabetes is also consistent with previous findings [6,8-13]. Gestational
diabetes is independently and significantly associated
with an increased risk of preeclampsia and an even minor
degree of glucose intolerance is associated with preeclampsia [14-16]. Similarly there was a positive association
between pregestational diabetes and preeclampsia risk.
This finding is also consistently seen in previous studies
[15,17-20]. This association is based on a small number of
cases and control subjects and the confidence interval is
wide.
The findings from our study are biologically plausible
for reason that epidemiological and clinical data document a close association between insulin resistance, type
2 diabetes, and hypertension. Hyperinsulinemia has been
shown to stimulate the proliferation of vascular smooth
muscle cells, enhance acute sympathetic nervous system
activity and modify transmembrane cation transport, as
well as renal sodium retention and associated endothelial
dysfunction. All of these alterations may contribute to
blood pressure elevations [21,22].
Our observation of a positive association between family history of chronic hypertension and risk of preeclampsia is consistent with several previous reports [23-25].
These studies reported an increase in risk of preeclampsia with positive family history of chronic hypertension.
Our results suggest that family history of hypertension
reflects genetic and behavioral factors whereby women
may be predisposed to an increased preeclampsia risk.
Family history of chronic hypertension is a proxy measure for hereditary factors as well as common environmental or behavioral exposures that may underlie
preeclampsia risk [26,27]. To the best of our knowledge,
this is the first analysis in Pakistan to assess the effects of
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Table 1: Table showing demographic, socio-economic and obstetrical characteristics of cases and controls with
preeclampsia (PE) among women in maternity hospitals of Karachi and Rawalpindi (January 2006-December 2007)
Variables

Cases (131)
n (%)

Controls (262)
n (%)

P-value

Nulliparous women

64 (48.9)

130 (49.6)

0.915

Parous women

67 (51.1)

132 (50.4)

≤ 18

5 (3.8)

12 (4.6)

19-34

114 (87.0)

226 (86.6)

Parity

Mean maternal age (years)
0.935

≥ 35

12 (9.2)

23 (8.8)

Age at menarche

13.0 ± 1.2

13.0 ± 1.3

0.476

Maternal Smoking

5 (3.8)

16 (6.1)

0.42

Less than 8 years

41 (31.3)

69 (27.2)

0.696

8-12years

64 (48.9)

131 (51.6)

More than 12 years

26 (19.8)

54 (21.3)

Owned

91 (69.5)

160 (61.1)

Rented

40 (30.5)

102 (38.9)

≤3

73 (55.7)

145 (55.3)

>3

58 (44.3)

117 (44.7)

≤6

63 (48.1)

147 (56.1)

>6

68 (51.9)

115 (43.9)

Private job

42 (32.1)

98 (37.4)

Government job

50 (38.2)

108 (41.2)

Business

29 (22.1)

44 (16.8)

Others

10 (7.6)

12 (4.6)

>10000

45 (34.4)

118 (45.2)

4001-10000

65 (49.6)

120 (46.0)

≤ 4000

21 (16.0)

23 (8.8)

Gestational diabetes

16 (12.4)

05 (1.9)

< 0.001

Urinary tract infection

39 (31.0)

47 (18.5)

0.006

Pregestational Diabetes
Mellitus

07 (5.6)

02 (0.8)

0.004

Family History of DM

56 (43.8)

75 (29.6)

0.006

Family History of
Hypertension

76 (58.9)

100 (38.5)

< 0.001

Perceived Stress Score*

22 ± 6.1

20 ± 6.2

0.002

Husband's Age*

33.5 ± 12.9

33.5 ± 13.5

0.981

Maternal education

Ownership Status
0.102

Number of rooms in
household
0.943

Mean number of household
members
0.133

Husband's occupation
0.296

Monthly household income
0.034
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Table 1: Table showing demographic, socio-economic and obstetrical characteristics of cases and controls with
preeclampsia (PE) among women in maternity hospitals of Karachi and Rawalpindi (January 2006-December 2007)
Condom use around the
time of conception

17 (13.5)

34 (13.7)

0.954

Height* (centimeters)

150.8 ± 22.3

149.5 ± 23.5

0.592

Weight*(kilograms)

57.3 ± 15.8

55.0 ± 12.2

0.002

<18.5

18 (13.7)

37 (14.1)

0.502

18.5-24.9

78 (59.5)

171 (65.3)

25-29.9

23 (17.6)

39 (14.9)

BMI‡

≥ 30

12 (9.2)

15 (5.7)

Gestational age* (weeks)

36.2 ± 2.2

37.0 ± 1.2

<0.001

A+/A-

30 (24)

47 (18.4)

0.326

B+/B-

42 (33.6)

75 (29.4)

AB+/AB-

11 (8.8)

30 (11.8)

O+/O-

42 (33.6)

103 (40.4)

Rh Factor positive

120 (96)

231 (90.6)

Rh factor negative

5 (4)

24 (9.4)

Blood Group

0.067

Sex of Baby
Male

77 (61.1)

151 (58.5)

Female

49 (38.9)

107 (41.5)

0.628

*Plus-minus values are means ± SD.
‡BMI = body mass index, calculated by dividing weight in kilograms with height in meters squared.

family history of chronic hypertension on preeclampsia
risk.
Women's family history of chronic hypertension is an
important and easy to acquire clinical risk marker of
preeclampsia compared to the biochemical markers.
During the past 100 years numerous clinical, biophysical,
and biochemical tests have been suggested to identify
women who are at increased risk for future development
of preeclampsia. Unfortunately, these biomarkers have
limited sensitivity and are expensive enough for our
women to be clinically useful for the prediction of preeclampsia in our setting. The family history of hypertension
questions can be used as an inexpensive and feasible
screening tool to identify pregnant women in a developing country like Pakistan to monitor the signs of preeclampsia during early pregnancy.
Our study showed an association of mental stress during pregnancy and development of preeclampsia. Depression and anxiety in early pregnancy are associated with
risk for preeclampsia, a risk further increased if associated with vaginosis [28] Stressful work environment and
stressful home environment are also associated with
preeclampsia [29]. The prenatal stress alters maternal
physiology and immune function in a manner consistent
with increased risk of pregnancy complications such as
preeclampsia and premature labor [30]. In another study

work-related psychosocial strain increased the risk of PE
[31]. Vasoconstriction in preeclampsia may develop early
in pregnancy. Indeed, increased uterine artery resistance
in maternal anxiety could be a primary manifestation or
even the cause of preeclampsia [32,33].
Several limitations must be considered when interpreting the results from our study. First of all recall bias and
inability to establish temporality between preeclampsia
and certain variables are inherent due to the case control
study design. We cannot exclude the possibility that our
results could be partially confounded by unidentified risk
factors. Our study would have been strengthened by a
larger number of preeclamptic women, particularly those
with histories of exposures like extremes of age, condom
use, women with change in paternity. Prepregnancy
weights and body mass index (BMI) were assessed by
subtracting the average weight gain from the full term
maternal weight which might not be a good proxy measure. There is certainly underreporting of smoking, condom use and therefore we could not establish a
relationship between them and preeclampsia risk.
Dietary and other lifestyle changes relationship with
preeclampsia not analyzed in this study. This being a hospital based study; the results may not be applicable to the
general population at large. We could not establish a relationship between certain factors like condom use and
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Table 2: Table based on multivariable analysis showing the association of independent variables with PE risk among
women in maternity hospitals of Karachi and Rawalpindi (January 2006-December 2007)
Variables

Matched unadjusted OR(95% CI)

Matched adjusted OR(95%CI)

Gestational diabetes

6.40 (2.34, 17.4)

6.57 (1.94, 22.25)

Urinary tract infection

2.0 (1.21, 3.49)

NS

Pregestational Diabetes Mellitus

6.56 (1.36, 31.7)

7.36 (1.37, 33.66)

Family History of DM

1.88 (1.18, 3.00)

NS

Family History of Hypertension

2.24 (1.45, 3.46)

2.06 (1.27, 3.35)

Perceived Stress Score*
(for every 5 unit change)

1.33 (1.21, 1.46)

1.32 (1.19, 1.46)

Husband's Age*

1.0 (0.98, 1.02)

NS

Condom use around the time of
conception

1.02 (0.50, 2.11)

NS

Height* (centimeters)

1.01 (.98, 1.05)

NS

Weight*(kilograms)

1.02 (1.01, 1.04)

NS

BMI

1.05 (1.00, 1.11)

NS

Sex of Baby
Male
Female

1.15 (0.74, 1.78)1

NS

> 10000

0.35 (0.16 " 0.76)

NS

4001 " 10000

0.54 (0.26 " 1.13)

NS

< 4000

1

Monthly Household Income

* Plus-minus values are means ± SD.
NS Nonsignificant
Multivariate adjusted model was adjusted for maternal age, socioeconomic status measured by ownership of house, number of household
members and monthly household income, urine tract infection during pregnancy, family history of diabetes mellitus,
maternal weight, Rh factor.

change of paternity because of their low prevalence of
these exposures in our population. The risk factors of
preeclampsia may be different in early vs. late onset of
preeclampsia but we did not record the gestational age of
PE diagnosis and therefore we were unable to categorize
PE in early vs. late onset.
The study was conducted in accordance with the American College of Obstetricians & Gynecologists (ACOG)
criteria and ICD 9& 10 for preeclampsia. The American
College of Obstetricians & Gynecologists (ACOG) definition for preeclampsia was used to avoid misclassification
of preeclampsia with gestational hypertension as well as
superimposed preeclampsia [34]. The participation rate
for both control and cases subjects was 100%, so there
was no selection bias. The data collected was mainly by
classified doctors in gynecological and Obstetrics
Departments with rich clinical as well as research experience and therefore, the quality of data collected was good
and accurate.

Some of the predictors like Diabetes and GDM are
modifiable and preventable and others like family history
of preeclampsia even if not amenable to change but still
are useful in identification of women at high risk who
require extra vigilance. If greater awareness of the associated risk factors leads to earlier diagnosis and improved
management, there may be scope for reducing a proportion of the morbidity and mortality from preeclampsia.

Conclusion
Factors like gestational diabetes, pregestational diabetes,
family history of hypertension and mental stress during
pregnancy can be used as screening tools for preeclampsia prediction. These factors can help identify pregnant
women who need closer monitoring for the signs of
preeclampsia during early pregnancy. Every woman during the antenatal visit should also be asked for the family
history hypertension in order to better estimate the possible risk of developing preeclampsia. These risk factors
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should be considered for the designs of future studies of
preeclampsia in our population of Pakistani women.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
US was the PI of the study who developed the protocol as a part of her Master's thesis. She developed the design of the study, carried out the statistical
analyses, participated in interpreting results, and drafted the manuscript. JH
was the supervisor and she supervised the protocol, participated in interpreting results. NZ was the subject expert and gave his expertise during the study
design phase. AS participated in the design of the study, coordinated the data
collection in Rawalpindi hospitals and contributed to the manuscript writing.
ZQ supervised the data entry and data editing along with statistical expertise.
SS provided support for the protocol writing, participated in interpreting
results and manuscript writing. All authors have reviewed the final manuscript.
Acknowledgements
This study was funded by University Research Council (URC), Aga Khan University Hospital, AKUH Research grant no. 051017MSC
This research was also supported by the International Maternal and Child
Health Research Training Program (IMCHRT. FIC, NIH # 5 D43 TW05497-03), Aga
Khan University and University of Alabama at Birmingham (UAB).
I am thankful to Dr James Walker, (Associate professor, Department of Gynecology and Obstetrics, St James University Hospital, Leeds) for his help during protocol development through email correspondence.
Author Details
1Division of Epidemiology/Biostatistics, Department of Community Health
Sciences, Aga Khan University, Karachi, Pakistan, 2Combined Military Hospital,
Rawalpindi, Pakistan and 3Department of Obstetrics/Gynecology, Aga Khan
University Hospital AKUH, Karachi, Pakistan
Received: 26 October 2009 Accepted: 30 April 2010
Published: 30 April 2010
©
This
BMC
2010
is
article
Women's
an
Shamsi
Open
is available
Health
et
Access
al; licensee
2010,
from:
article
10:14
http://www.biomedcentral.com/1472-6874/10/14
BioMed
distributed
Central
under
Ltd.
the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References
1. Sibai B, Dekker G, Kupferminc M: Pre-eclampsia. Lancet 2005,
365(9461):785-99.
2. Landau R, Irion O: Recent data on the physiopathology of preeclampsia
and recommendations for treatment. Rev Med Suisse 2005, 1(4):290-25.
3. Mostello D, Catlin TK, Roman L, Holcombe WL Jr., Leet T: Preeclampsia in
the parous woman: who is at risk? Am J Obstet Gynecol 2002,
187(2):425-9.
4. Ventura SJ, Martin JA, Menacker F, Hamilton BE: Births: final data for
1999. 2001.
5. Pakistan Demographic and health survey 2006-07. National Institute of
Population Studies, Islamabad, Pakistan; 2008.
6. Duckitt K, Harrington D: Risk factors for pre-eclampsia at antenatal
booking: systematic review of controlled studies. Bmj 2005,
330(7491):565.
7. Cohen S, Kamarck T, Mermelstein R: A global measure of perceived
stress. Journal of Health and Social Behavior 1983, 24:386-96.
8. Berkowitz KM: Insulin resistance and preeclampsia. Clin Perinatol 1998,
25(4):873-85.
9. Ostlund I, Haglund B, Hanson U: Gestational diabetes and preeclampsia.
Eur J Obstet Gynecol Reprod Biol 2004, 113(1):12-6.
10. England LJ, Levine RJ, Qian C, Soule LM, Schisterman EF, Yu KF: Glucose
tolerance and risk of gestational diabetes mellitus in nulliparous
women who smoke during pregnancy. Am J Epidemiol 2004,
160(12):1205-13.
11. Hiilesmaa V, Suhonen L, Teramo K: Glycaemic control is associated with
pre-eclampsia but not with pregnancy-induced hypertension in
women with type I diabetes mellitus. Diabetologia 2000, 43(12):1534-9.
12. Starcevic V, Djelmis J: Glycemic control and the risk of preeclampsia in
women with gestational diabetes mellitus. Acta Med Croatica 2004,
58(5):367-71.
13. Yogev Y, Xenakis EM, Langer O: The association between preeclampsia
and the severity of gestational diabetes: the impact of glycemic
control. Am J Obstet Gynecol 2004, 191(5):1655-60.

Page 7 of 7

14. Drobny J: Metabolic syndrome and the risk of preeclampsia. Bratisl Lek
Listy 2009, 110(7):401-3.
15. Sun Y, Yang H, Sun WJ: Risk factors for pre-eclampsia in pregnant
Chinese women with abnormal glucose metabolism. Int J Gynaecol
Obstet 2008, 101(1):74-6.
16. Barden A, Singh R, Walters BN, Ritchie J, Roberman B, Beilin LJ: Factors
predisposing to pre-eclampsia in women with gestational diabetes. J
Hypertens 2004, 22(12):2371-8.
17. Kilpatrick DC: Preeclampsia and diabetes. Am J Obstet Gynecol 1997,
177(1):243.
18. Siddiqi T, Rosen B, Mimouni F, Khoury J: Hypertension during pregnancy
in insulin-dependant diabetic women. Obstet Gynecol 1991, 77:514-9.
19. Sibai BM, Caritis S, Hauth J, Lindheimer M, VanDorsten JP, MacPherson C:
Risks of preeclampsia and adverse neonatal outcomes among women
with pregestational diabetes mellitus. In Am J Obstet Gynecol Volume
182. Issue 2 National Institute of Child Health and Human Development
Network of Maternal-Fetal Medicine Units; 2000:364-9.
20. Sibai BM: Risk factors, pregnancy complications, and prevention of
hypertensive disorders in women with pregravid diabetes mellitus. J
Matern Fetal Med 2000, 9(1):62-5.
21. Reaven GM, Lithell H, Landsberg L: Hypertension and associated
metabolic abnormalities--the role of insulin resistance and the
sympathoadrenal system. N Engl J Med 1996, 334(6):74-81.
22. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L: Effect
of insulin and glucose infusions on sympathetic nervous system
activity in normal man. Diabetes 1 1981, 30(3):219-25.
23. Ness RB, Markovic N, Bass D, Harger G, Roberts JM: Family history of
hypertension, heart disease, and stroke among women who develop
hypertension in pregnancy. Obstet Gynecol 2003, 102(6):1366-71.
24. Sanchez SE, Zhang C, Qiu CF, Williams MA: Family history of
hypertension and diabetes in relation to preeclampsia risk in Peruvian
women. Gynecol Obstet Invest 2003, 56(3):128-32.
25. Qiu C, Williams MA, Leisenring WM, Sorensen TK, Frederick IO, Dempsey
JC, Luthy DA: Family History of Hypertension and Type 2 Diabetes in
Relation to Preeclampsia Risk. Hypertension 2003, 41:408-13.
26. Mahomed K, Williams MA, Woelk GB, Jenkins-Woelk L, Mudzamiri S,
Longstaff L: Risk factors for pre-eclampsia among Zimbabwean
women: maternal arm circumference and other anthropometric
measures of obesity. Paediatr Perinat Epidemiol 1998, 12(3):253-62.
27. Merviel P, Touzart L, Deslandes V, Delmas M, Coicaud M, Gondry J: Risk
factors of preeclampsia in single pregnancy. J Gynecol Obstet Biol
Reprod (Paris) 2008, 37(5):477-82.
28. Kurki T, Hiilesmaa V, Raitasalo R, Mattila H, Ylikorkala O: Depression and
anxiety in early pregnancy and risk for preeclampsia. Obstet Gynecol
2000, 95(4):487-90.
29. Qiu C, Williams M A, Calderon-Margalit R, Cripe S M, Sorensen T K:
Preeclampsia Risk in Relation to Maternal Mood and Anxiety Disorders
Diagnosed Before or During Early Pregnancy. American Journal of
Hypertension 2009, 22(4):397-402.
30. Landsbergis PA, Hatch MC: Psychosocial work stress and pregnancyinduced hypertension. Epidemiology 1996, 7(4):346-51.
31. Klonoff-Cohen HS, Cross JL, Pieper CF: Job stress and preeclampsia.
Epidemiology 1996, 7(3):245-9.
32. Sullivan P, Schoentgen S, DeQuattro V, Procci W, Levine D, Meulen J Van
der, Bornheimer J: Anxiety, anger, and neurogenic tone at rest and in
stress in patients with primary hypertension. Hypertension 1981, 6(Pt
2):119-123.
33. Potter WZ, Manji HK: Catecholamines in depression: an update. Clin
Chem 1994, 40(2):279-87.
34. Schroeder BM: ACOG practice bulletin on diagnosing and managing
preeclampsia and eclampsia. American College of Obstetricians and
Gynecologists. Am Fam Physician 2002, 66(2):330-1.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1472-6874/10/14/prepub
doi: 10.1186/1472-6874-10-14
Cite this article as: Shamsi et al., A multicentre matched case control study
of risk factors for Preeclampsia in healthy women in Pakistan BMC Women's
Health 2010, 10:14

